Phibro Animal Health Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
10.6%projected annual EPS growth
Analyst Coverage
5analysts covering
FY EPS (est.)
$3.07next fiscal year
Monitoring Framework
Key Performance Indicators
Consolidated Net Sales Quarterly383.5MTarget: 1460000000 to 1500000000
Adjusted EBITDA Quarterly60.8MTarget: 247000000 to 255000000
Adjusted Diluted EPS Quarterly0.8Target: 2.98 to 3.10
Watch Items
- Integration of Zoetis MFA Portfolio
- Regulatory Changes in Brazil on Antimicrobials
Research as of 20 Jun 2026